Daesung Microbiological Labs. Co. Ltd Logo

Daesung Microbiological Labs. Co. Ltd

Develops, manufactures, and distributes animal pharmaceuticals and vaccines.

036480 | KO

Overview

Corporate Details

ISIN(s):
KR7036480002
LEI:
Country:
South Korea
Address:
경기도 의왕시 덕영대로 103, 의왕시

Description

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 749.2 KB
2025-06-26 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-06-23 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 14.1 KB
2025-05-26 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 14.5 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 756.0 KB
2025-03-26 00:00
정기주주총회결과
Korean 25.7 KB
2025-03-18 00:00
감사보고서제출
Korean 18.8 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 928.0 KB
2025-03-10 00:00
주주총회소집공고
Korean 120.2 KB
2025-02-25 00:00
주주총회소집결의
Korean 9.2 KB
2025-02-11 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-02-11 00:00
현금ㆍ현물배당결정
Korean 8.8 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
분기보고서 (2024.09)
Korean 653.8 KB
2024-08-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB

Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Daesung Microbiological Labs. Co. Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.